Design and biological evaluation of 3-substituted quinazoline-2,4(1 H ,3 H )-dione derivatives as dual c-Met/VEGFR-2-TK inhibitors

Abstract

The dual c-Met/vascular endothelial growth factor receptor 2 (VEGFR-2) TK inhibition is a good strategy to overcome therapeutic resistance to small molecules VEGFR-2 inhibitors. In this study, we designed 3-substituted quinazoline-2,4(1 H ,3 H )-dione derivatives as dual c-Met/VEGFR-2 TK inhibitors. We introduced new synthetic methods for reported derivatives of 3-substituted quinazoline-2,4(1 H ,3 H )-dione 2a – g , in addition to the preparation of some new derivatives namely, 3 and 4a – j . Three compounds namely, 2c , 4b , and 4e showed substantial amount of inhibition for both c-Met and VEGFR-2 TK (IC 50 range 0.052–0.084 µM). Both compounds 4b , 4e showed HB with highly conserved residue Asp1222 in the HB region of c-Met TK. For VEGFR-2 TK, compound 4b showed HB with a highly conserved residue Asp1046 in the HB region. Compound 4e showed HB with Glu885 and Asp1046. Moreover, in silico prediction of pharmacokinetic and physicochemical parameters of target compounds was carried out using SwissADME website. The quinazoline-2,4(1 H ,3 H )-dione derivatives are promising antiproliferative candidates that require further optimisation. Highlights New 3-substituted quinazoline-2,4(1 H ,3 H )-dione derivatives were synthesised and characterised. Compounds 4b and 4e showed higher cytotoxic activity than cabozantinib against HCT-116 colorectal cell lines. Both compounds 4b and 4e showed less toxicity to WI38 normal cell line compared to HCT 116 colon cancer cell line. Compound 4b was superior to cabozantinib in VEGFR-2 inhibition while compound 2c was equipotent to cabozantinib. Compounds 4b and 4e showed remarkable c-Met inhibitory activity. Compounds 4b and 4e arrested cell cycle and induced significant levels of apoptosis. In silico ADME prediction revealed high oral bioavailability and enhanced water solubility of target compounds as compared to cabozantinib. Target compounds interacted with both c-Met and VEGFR-2 active site in similar way to ca...

Two Novel Regioisomeric Series of Bis-pyrazolines: Synthesis, In Silico Study, DFT Calculations, and Comparative Antibacterial Potency Profile against Drug-Resistant Bacteria; MSSA, MRSA, and VRSA

“…To check the affinity of the newly synthesized bis-pyrazoline derivatives against methicillin-resistant S. aureus (MRSA), a molecular docking study was performed. − The minimum binding energy confirmed that the target was successfully docked with the ligand molecules. The obtained data suggested that the studied bis-pyrazoline derivatives were fit docked to the effective site pockets of the host in the range of −13.1 to −12.7 kcal/mol.…”

Novel N -Arylmethyl-aniline/chalcone hybrids as potential VEGFR inhibitors: synthesis, biological evaluations, and molecular dynamic simulations

“…All newly synthetic derivatives were investigated in vitro for their inhibitory activities against VEGFR-2 as a potential molecular target. The VEGFR-2 Kinase Assay Kit (BPS-Bioscience, #78857, USA) 81 , 82 was used for testing the VEGFR tyrosine kinase activity 83 , 84 . Sorafenib was used as a positive control.…”

Bioactivities and Action Mechanisms of Ellipticine Derivatives Reported Prior to 2023

“…The structure of ellipticine encompasses an indole that is fused with an isoquinoline moiety, endowing it with planar structural characteristics. We performed absorption, distribution, metabolism, and excretion (ADME) prediction of ellipticine via an online service [12] (http://www.swissadme.ch/index.php). The results showed that this alkaloid complies with Lipinski's Rule of Five.…”